← Browse by Condition
Medical Condition
metastatic gastric adenocarcinoma
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3, Phase 1, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for metastatic gastric adenocarcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — metastatic gastric adenocarcinoma Clinical Trials
How many clinical trials are currently recruiting for metastatic gastric adenocarcinoma?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for metastatic gastric adenocarcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for metastatic gastric adenocarcinoma?
metastatic gastric adenocarcinoma research spans Phase 1 (3 trials), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a metastatic gastric adenocarcinoma clinical trial?
Eligibility criteria for metastatic gastric adenocarcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 3
Phase 2 2
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05677490 Phase 3
Recruiting
Enrollment
382 pts
Location
United States, Puert...
Sponsor
Alliance for Clinical Trials i...
NCT06324357 Phase 1, Phase 2
Recruiting
Enrollment
768 pts
Location
United States, Belgi...
Sponsor
Boehringer Ingelheim
NCT05927857 Phase 1, Phase 2
Recruiting
Enrollment
45 pts
Location
Taiwan
Sponsor
National Health Research Insti...
NCT06675136 Phase 1
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
City of Hope Medical Center
Related Conditions
advanced esophageal adenocarcinoma (1) advanced gastric adenocarcinoma (1) advanced gastroesophageal junction adenocarcinoma (1) clinical stage iii esophageal adenocarcinoma ajcc v8 (1) clinical stage iii gastric cancer ajcc v8 (1) clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8 (1) clinical stage iv esophageal adenocarcinoma ajcc v8 (1) clinical stage iv gastric cancer ajcc v8 (1) clinical stage iv gastroesophageal junction adenocarcinoma ajcc v8 (1) metastatic esophageal adenocarcinoma (1) metastatic gastroesophageal junction adenocarcinoma (1) unresectable esophageal adenocarcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology